#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13428	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2145	623.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1502	1502	C	768	C,G	714,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24026	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3714	645.5	0	.	n	.	0	T695C	SNP	695	695	T	1049	1049	C	715	C	679	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24026	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3714	645.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1691	1691	A	833	A	782	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24026	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3714	645.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2325	2325	C	783	C	729	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24026	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3714	645.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2399	2399	A	755	A,G	718,2	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24026	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3714	645.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2951	2951	C	781	C	731	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	1900	folP	852	852	100.0	folP.l6.c30.ctg.1	1716	110.1	1	SNP	p	R228S	0	.	.	682	684	CGC	1202	1204	CGC	198;199;202	C;G,A;C	191;192,1;194	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5240	gyrA	2751	2751	99.75	gyrA.l15.c4.ctg.1	3435	152.1	0	.	p	.	0	V45I	NONSYN	133	135	GTT	479	481	ATT	167;164;161	A;T;T	157;152;154	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5240	gyrA	2751	2751	99.75	gyrA.l15.c4.ctg.1	3435	152.1	0	.	p	.	0	V290I	NONSYN	868	870	GTT	1214	1216	ATT	157;155;155	A;T;T	150;147;145	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5240	gyrA	2751	2751	99.75	gyrA.l15.c4.ctg.1	3435	152.1	0	.	p	.	0	A684T	NONSYN	2050	2052	GCC	2396	2398	ACC	181;182;185	A;C;C	175;179;178	.	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5240	gyrA	2751	2751	99.75	gyrA.l15.c4.ctg.1	3435	152.1	1	SNP	p	S91F	0	.	.	271	273	TCC	617	619	TCC	162;165;169	T;C;C	148;154;160	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5240	gyrA	2751	2751	99.75	gyrA.l15.c4.ctg.1	3435	152.1	1	SNP	p	D95G	0	.	.	283	285	GAC	629	631	GAC	178;175;175	G;A,G,T;C	168;164,1,1;167	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	539	5240	gyrA	2751	2751	99.75	gyrA.l15.c4.ctg.1	3435	152.1	1	SNP	p	D95N	0	.	.	283	285	GAC	629	631	GAC	178;175;175	G;A,G,T;C	168;164,1,1;167	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1492	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1334	111.3	0	.	p	.	0	S32W	NONSYN	94	96	TCG	424	426	TGG	180;178;177	T;G;G	166;168;166	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1492	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1334	111.3	0	.	p	.	0	D79N	NONSYN	235	237	GAT	565	567	AAT	185;184;182	A;A;T	180;179;175	.	.
mtrR.WHO_U_01459	mtrR.WHO_U_01459	1	1	539	1492	mtrR	633	633	99.68	mtrR.l6.c30.ctg.1	1334	111.3	1	SNP	p	G45D	0	.	.	133	135	GGC	463	465	GGC	202;197;197	G;G;C	192;187;186	mtrR.WHO_U_01459:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	744	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1027	72.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5020	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2916	171.4	1	SNP	p	D86N	0	.	.	256	258	GAC	545	547	GAC	221;221;221	G;A;C	205;207;207	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	27	5020	parC	2304	2304	99.83	parC.l15.c4.ctg.1	2916	171.4	1	SNP	p	S88P	0	.	.	262	264	TCC	551	553	TCC	222;223;221	T,C;C;C	207,1;211;206	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4300	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2531	168.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1435	1437	GGC	208;204;204	G,T,A;G;C,A	193,1,1;190;189,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	0	.	p	.	0	R213W	NONSYN	637	639	CGG	993	995	TGG	217;215;219	T;G;G	198;196;200	.	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1287	1289	GCA	189;189;189	G;C,T;A	173;172,1;175	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1290	1292	ATC	191;189;189	A;T;C	176;176;176	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1302	1304	GTG	194;194;198	G;T;G	183;181;187	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1302	1304	GTG	194;194;198	G;T;G	183;181;187	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1806	1808	ACC	215;216;215	A;C;C	195;201;200	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1860	1862	GCG	187;187;184	G;C,T;G	165;150,1;152	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1860	1862	GCG	187;187;184	G;C,T;G	165;150,1;152	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1983	1985	GGC	143;141;142	G;G;C	134;133;133	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1992	1994	GGC	146;147;147	G;G;C	135;137;136	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	539	3818	penA	1749	1749	99.94	penA.l15.c4.ctg.1	2421	157.0	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2010	2012	CTG	147;152;156	C,G;T;G	114,2;115;119	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5384	ponA	2397	2397	99.96	ponA.l6.c4.ctg.1	3148	170.3	1	SNP	p	L421P	1	L421P	NONSYN	1261	1263	CTG	1625	1627	CCG	206;205;203	C;C;G	179;185;182	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2150	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1680	126.9	0	.	p	.	0	S22G	NONSYN	64	66	AGC	370	372	GGC	155;158;158	G;G;C	144;145;144	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2150	porA	1146	1146	99.83	porA.l15.c4.ctg.1	1680	126.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	552	552	C	150	C	130	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	T18M	NONSYN	52	54	ACG	317	319	ATG	193;194;193	A;T;G	178;182;182	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	692	694	CAA	201;202;206	C;A;A	189;188;184	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	E212D	NONSYN	634	636	GAA	899	901	GAT	218;217;220	G;A;T	207;207;209	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	H213D	NONSYN	637	639	CAT	902	904	GAT	219;214;212	G;A;T	208;203;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	V215A	NONSYN	643	645	GTT	908	910	GCT	216;216;216	G;C,A;T	204;203,1;202	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	S220T	NONSYN	658	660	AGC	923	925	ACT	210;207;209	A;C;T	190;199;197	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	L221P	NONSYN	661	663	CTG	926	928	CCG	208;209;210	C;C;G	202;203;204	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1034	1036	ATG	221;218;220	A;T;G	208;208;210	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1037	1039	AGC	218;217;216	A;G;C	207;206;203	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1040	1042	GGT	216;215;215	G;G;T	205;203;202	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1154	1156	AAC	216;217;218	A;A;C	206;209;206	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2484	porB1b	1047	1047	98.57	porB1b.l15.c17.ctg.1	1450	169.8	1	SNP	p	G120K	0	.	.	358	360	GGC	623	625	GGC	190;191;192	G;G;C	182;185;184	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9462	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4923	191.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1130	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1041	107.9	1	SNP	p	V57M	1	.	.	169	171	ATG	519	521	ATG	210;210;209	A;T;G	201;203;201	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	M177T	NONSYN	529	531	ATG	904	906	ACG	362;356;351	A;C;G	344;339;338	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	925	927	GAC	321;317;314	G;A;C	317;311;307	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	T190M	NONSYN	568	570	ACG	943	945	ATG	302;299;301	A;T;G,A	300;298;298,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	L194S	NONSYN	580	582	TTA	955	957	TCA	303;301;302	T;C;A	300;299;299	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1000	1002	CAG	309;306;306	C;A;G	303;300;300	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1021	1023	CTT	298;295;296	C;T;T	296;293;294	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1042	1044	AGT	279;279;284	A;G;T	273;272;274	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1111	1113	CCG	353;354;356	C;C;G	342;343;346	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1213	1215	TCG	457;453;457	T;C,T;G	434;428,1;431	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1384	1386	AAA	302;299;297	A;A;A	285;282;282	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1387	1389	AAG	289;287;283	A;A;G	273;272;264	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1402	1404	CAC	241;241;240	C;A;C	239;228;236	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1441	1443	GAA	231;233;233	G;A;A	230;232;233	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1519	1521	ACG	173;171;168	A;C;G	172;171;165	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1570	1572	ATT	224;223;220	A;T;T	219;217;216	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1573	1575	AGT	218;218;219	A;G;T	214;214;214	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1612	1614	CTA	227;232;234	C;T;A	219;226;227	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1654	1656	AAT	158;159;161	A;A;T	156;156;159	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1723	1725	TCA	241;240;242	T;C;A	230;229;225	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1747	1749	ATG	252;255;255	A;T;G	237;242;243	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2041	2043	ACC	501;505;508	A;C;C	467;477;477	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	8886	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2598	340.5	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2137	2139	GAA	526;525;524	G,T;A;A	502,1;504;501	.	Tetracycline resistance
